Medicated Shampoo Market To Reach $20.84 Billion By 2030

Medicated Shampoo Market Growth & Trends

The global medicated shampoo market size is expected to reach USD 20.84 billion by 2030, registering a CAGR of 4.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising concerns over hair related issues, growing consumer inclination towards hair maintenance, and new formulated product launches on a global level are projected to remain prominent market trends. Furthermore, rising awareness of maintaining beauty among working class adults in emerging economies including China, India, and Vietnam is projected to upscale the requirements of medicated shampoo over the next few years.

North America accounted for more than 30.0% share of the overall revenue in 2018. Strong foothold of hair care companies including Johnson & Johnson Consumer Inc. and Proctor & Gamble through extensive distribution networks in U.S. and Canada is expected to provide high market visibility of medicated shampoo. Furthermore, shifting inclination towards organic shampoo as a result of rising concerns over hazardous effects associated with the synthetically derived chemical ingredients is likely to force industry participants to incorporate natural extracts such as neem, strawberry, and other fruit flavors in the formulation of finished goods.

Dandruff and seborrheic dermatitis treatment generated a revenue of USD 3.1 billion in 2018. These products are used to remove the white flakes, reduce itchiness, and remove dead skin to give a clear and clean scalp. Rising concerns over anti-dandruff and excess oil control among the buyers have enabled the manufacturers to customize the products accordingly to meet desired specifications given by users.

Key industry participants include Procter & Gamble; Johnson & Johnson Consumer Inc.; Coty Inc.; Avalon Natural Products; Kao Corporation; Sanofi-Aventis Groupe; Himalaya Herbal Healthcare; and Summers Laboratories Inc. Product innovation is expected to remain a key strategy among the industry participants over the next few years.

In March 2017, Proctor & Gamble launched six-variants of anti-dandruff shampoos under the brand name, “Head & Shoulders Men Ultra”. These products are manufactured by using the high performance boosters including mint and caffeine, which are available in six variants including Total Care, Instant Scalp Relief, Max Oil Control, Hair Booster, Sports Fresh, and Old Spice.

 Request a free sample copy or view report summary: Medicated Shampoo Market Report

Medicated Shampoo Market Report Highlights

• Psoriasis treatment is expected to register significant growth with a CAGR of 4.8% over the forecast period.

• Online distribution channels are expected to register the fastest CAGR of 7.1% over the forecast period.

• Asia Pacific medicated shampoo market is expected to register the fastest CAGR of 5.1% during the forecast period.

Medicated Shampoo Market Segmentation

Grand View Research has segmented the global medicated shampoo market based on treatment, distribution channel, and region:

Medicated Shampoo Treatment Outlook (Revenue, USD Million, 2018 - 2030)

• Dandruff & Seborrheic Dermatitis

• Psoriasis

• Tinea Capitis

• Head Lice

• Allergic Reactions

Medicated Shampoo Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hypermarkets / Supermarkets

• Convenience Stores

• Online

• Other Distribution Channels

Medicated Shampoo Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia & New Zealand

• Central & South America

  • Brazil

• Middle East & Africa

  • South Africa

List Of Key Players Medicated Shampoo Market

• Procter & Gamble

• Himalaya Wellness Company

• Johnson & Johnson Services, Inc.

• Unilever

• Henkel AG & Co. KGaA

• Kao Corporation

• Avalon Organics

• Summers Laboratories, Inc.

• Coty Inc.